{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T13:20:36Z","timestamp":1791292836026,"version":"4.1.0"},"reference-count":30,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2009,3]]},"DOI":"10.1097\/spc.0b013e328325d18d","type":"journal-article","created":{"date-parts":[[2009,5,21]],"date-time":"2009-05-21T18:53:48Z","timestamp":1242932028000},"page":"36-40","source":"Crossref","is-referenced-by-count":22,"title":["Measurement tools for gastrointestinal symptoms in radiation oncology"],"prefix":"10.1097","volume":"3","author":[{"given":"Catharine ML","family":"West","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan E","family":"Davidson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-7-20210126","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1136\/gut.2004.062596","article-title":"Gastrointestinal complications of pelvic radiotherapy: are they of any importance?","volume":"54","author":"Andreyev","year":"2005","journal-title":"Gut"},{"key":"R2-7-20210126","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/S0167-8140(97)00226-0","article-title":"Towards evidence based radiation oncology: improving the design, analysis, and reporting of clinical outcome studies in radiotherapy","volume":"46","author":"Bentzen","year":"1998","journal-title":"Radiother Oncol"},{"key":"R3-7-20210126","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1016\/j.ijrobp.2007.07.2363","article-title":"Grading-system-dependent volume effects for late radiation-induced rectal toxicity after curative radiotherapy for prostate cancer","volume":"70","author":"van der Laan","year":"2008","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R4-7-20210126","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/S0360-3016(97)00234-4","article-title":"Chronic rectal bleeding after high-dose conformal treatment of prostate cancer warrants modification of existing morbidity scales","volume":"38","author":"Hanlon","year":"1997","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R5-7-20210126","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1016\/0360-3016(95)00060-C","article-title":"Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC)","volume":"31","author":"Cox","year":"1995","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R6-7-20210126","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1016\/0360-3016(95)00059-8","article-title":"Late effects toxicity scoring: the SOMA scale","volume":"31","author":"Pavy","year":"1995","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R7-7-20210126","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/S1053-4296(03)00031-6","article-title":"CTCAE v3.0: development of a comprehensive grading system for the adverse effects of cancer treatment","volume":"13","author":"Trotti","year":"2003","journal-title":"Semin Radiat Oncol"},{"key":"R8-7-20210126","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/S1470-2045(07)70143-2","article-title":"Escalated-dose versus standard-dose conformal radiotherapy in prostate cancer: first results from the MRC RT01 randomised controlled trial","volume":"8","author":"Dearnaley","year":"2007","journal-title":"Lancet Oncol"},{"key":"R9-7-20210126","doi-asserted-by":"crossref","first-page":"5063","DOI":"10.1200\/JCO.2007.11.0197","article-title":"Use of patient-reported outcomes in phase III cancer treatment trials: lessons learned and future directions","volume":"25","author":"Ganz","year":"2007","journal-title":"J Clin Oncol"},{"key":"R10-7-20210126","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.radonc.2007.02.014","article-title":"The early toxicity of escalated versus standard dose conformal radiotherapy with neo-adjuvant androgen suppression for patients with localised prostate cancer: results from the MRC RT01 trial (ISRCTN47772397)","volume":"83","author":"Dearnaley","year":"2007","journal-title":"Radiother Oncol"},{"key":"R11-7-20210126","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1111\/j.1464-410X.2006.06560.x","article-title":"The quality of life of men with locally advanced prostate cancer during neoadjuvant hormone therapy: data from the Medical Research Council RT01 trial (ISRCTN 47772397)","volume":"99","author":"Stephens","year":"2007","journal-title":"BJU Int"},{"key":"R12-7-20210126","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/S1470-2045(07)70144-4","article-title":"TAME: development of a new method for summarising adverse events of cancer treatment by the Radiation Therapy Oncology Group","volume":"8","author":"Trotti","year":"2007","journal-title":"Lancet Oncol"},{"key":"R13-7-20210126","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1016\/j.ijrobp.2008.02.044","article-title":"Analysis of gastrointestinal and genitourinary morbidity of postoperative radiotherapy for pathologic T3 disease or positive surgical margins after radical prostatectomy using national cancer institute expanded common toxicity criteria","volume":"72","author":"Choo","year":"2008","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R14-7-20210126","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1016\/S1470-2045(07)70341-8","article-title":"Gastrointestinal symptoms after pelvic radiotherapy: a new understanding to improve management of symptomatic patients","volume":"8","author":"Andreyev","year":"2007","journal-title":"Lancet Oncol"},{"key":"R15-7-20210126","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.radonc.2004.05.001","article-title":"Audit of effectiveness of routine follow-up clinics after radiotherapy for cancer: a report of the REACT working group of ESTRO","volume":"73","author":"Ataman","year":"2004","journal-title":"Radiother Oncol"},{"key":"R16-7-20210126","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1016\/j.ijrobp.2007.04.054","article-title":"Improving the capture of adverse event data in clinical trials: the role of the International Atomic Energy Agency","volume":"69","author":"Davidson","year":"2007","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R17-7-20210126","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/j.ijrobp.2007.06.050","article-title":"Long-term treatment sequelae after external beam irradiation with or without hormonal manipulation for adenocarcinoma of the prostate: analysis of Radiation Therapy Oncology Group studies 85-31, 86-10, and 92-02","volume":"70","author":"Lawton","year":"2008","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R18-7-20210126","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1016\/j.ijrobp.2007.01.049","article-title":"Predictive factors for late genitourinary and gastrointestinal toxicity in patients with prostate cancer treated with adjuvant or salvage radiotherapy","volume":"68","author":"Feng","year":"2007","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R19-7-20210126","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1016\/j.ijrobp.2007.07.2354","article-title":"Clinical and dosimetric predictors of late rectal syndrome after 3D-CRT for localized prostate cancer: preliminary results of a multicenter prospective study","volume":"70","author":"Fiorino","year":"2008","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R20-7-20210126","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1016\/j.ijrobp.2007.11.037","article-title":"Development of a set of nomograms to predict acute lower gastrointestinal toxicity for prostate cancer 3D-CRT","volume":"71","author":"Valdagni","year":"2008","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R21-7-20210126","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1016\/j.ijrobp.2006.10.040","article-title":"Predictors for rectal and intestinal acute toxicities during prostate cancer high-dose 3D-CRT: results of a prospective multicenter study","volume":"67","author":"Vavassori","year":"2007","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R22-7-20210126","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/j.clnu.2008.02.005","article-title":"Citrulline as a biomarker of intestinal failure due to enterocyte mass reduction","volume":"27","author":"Crenn","year":"2008","journal-title":"Clin Nutr"},{"key":"R23-7-20210126","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1080\/00365520701579985","article-title":"A prospective study of faecal calprotectin and lactoferrin in the monitoring of acute radiation proctitis in prostate cancer treatment","volume":"43","author":"Hille","year":"2008","journal-title":"Scand J Gastroenterol"},{"key":"R24-7-20210126","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1111\/j.1365-2036.2008.03663.x","article-title":"Can biological markers act as noninvasive, sensitive indicators of radiation-induced effects in the gastrointestinal mucosa?","volume":"27","author":"Wedlake","year":"2008","journal-title":"Aliment Pharmacol Ther"},{"key":"R25-7-20210126","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.ijrobp.2007.06.054","article-title":"Long-term results of the M. D. Anderson randomized dose-escalation trial for prostate cancer","volume":"70","author":"Kuban","year":"2008","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R26-7-20210126","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/S0167-8140(03)00197-X","article-title":"A systematic review of acute and late toxicity of concomitant chemoradiation for cervical cancer","volume":"68","author":"Kirwan","year":"2003","journal-title":"Radiother Oncol"},{"key":"R27-7-20210126","doi-asserted-by":"crossref","first-page":"4096","DOI":"10.1200\/JCO.2007.13.3983","article-title":"Evaluation of early and late toxicities in chemoradiation trials","volume":"25","author":"Bentzen","year":"2007","journal-title":"J Clin Oncol"},{"key":"R29-7-20210126","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1111\/j.1365-2036.2008.03665.x","article-title":"Clinical trial: normal diet vs. partial replacement with oral E028 formula for the prevention of gastrointestinal toxicity in cancer patients undergoing pelvic radiotherapy","volume":"27","author":"McGough","year":"2008","journal-title":"Aliment Pharmacol Ther"},{"key":"R30-7-20210126","first-page":"35","article-title":"Treatment of gastrointestinal radiation injury with hyperbaric oxygen","volume":"34","author":"Marshall","year":"2007","journal-title":"Undersea Hyperb Med"},{"key":"R31-7-20210126","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.clon.2007.12.005","article-title":"Improved quality of life with hyperbaric oxygen therapy in patients with persistent pelvic radiation-induced toxicity","volume":"20","author":"Safra","year":"2008","journal-title":"Clin Oncol (R Coll Radiol)"}],"container-title":["Current Opinion in Supportive & Palliative Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/SPC.0b013e328325d18d","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T17:49:30Z","timestamp":1786038570000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/01263393-200903000-00007"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,3]]},"references-count":30,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2009]]}},"URL":"https:\/\/doi.org\/10.1097\/spc.0b013e328325d18d","relation":{},"ISSN":["1751-4258"],"issn-type":[{"value":"1751-4258","type":"print"}],"subject":[],"published":{"date-parts":[[2009,3]]}}}